MDxHealth (OTCMKTS:MXDHF) Trading Down 9.1% – Should You Sell?

by · The Markets Daily

MDxHealth SA (OTCMKTS:MXDHF – Get Free Report) shares were down 9.1% during trading on Monday . The stock traded as low as $0.25 and last traded at $0.25. Approximately 300 shares were traded during mid-day trading, a decline of 70% from the average daily volume of 1,000 shares. The stock had previously closed at $0.28.

MDxHealth Price Performance

The company has a quick ratio of 1.19, a current ratio of 1.25 and a debt-to-equity ratio of 1.45. The company’s 50 day moving average price is $0.25.

About MDxHealth

(Get Free Report)

MDxHealth SA, a commercial-stage precision diagnostics company, provides urologic solutions in the United States, Europe, and internationally. Its novel prostate cancer genomic testing solutions are SelectMDx, a non-invasive urine test; and ConfirmMDx, an epigenetic test, which provide physicians with a clinical pathway to identify clinically prostate cancer while minimizing the use of invasive procedures that are prone to complications.

Further Reading